NDC 42385-0915-30
Efavirenz, emtricitabine and tenofovir disoproxil fumarate 600 mg/1, 200 mg/1, 300 mg/1 TABLET, FILM COATED
Available — 2-Day Shipping
NDC
42385-0915-30
Generic Name
Efavirenz, emtricitabine and tenofovir disoproxil fumarate
Brand Name
Efavirenz, emtricitabine and tenofovir disoproxil fumarate
Strength
600 mg/1, 200 mg/1, 300 mg/1
Dosage Form
TABLET, FILM COATED
Route
ORAL
Package Size
—
Labeler
Laurus Labs Limited
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are indicated as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg. Efavirenz, emtricitabine and tenofovir disoproxil fumarate tablets are a three-drug combination of efavirenz (EFV), a non-nucleoside reverse transcriptase inhibitor, and emtricitabine (FTC) and tenofovir disoproxil fumarate (TD…
Source: FDA. For professional use only. Not a substitute for prescribing information.
View Product Detail →
See full specifications, request 2-day shipping, and create account to view pricing
All Efavirenz, emtricitabine and tenofovir disoproxil fumarate Strengths & Forms →
Compare all available NDC codes, strengths, and manufacturers
Wholesale and compliance resources
DSCSA compliance resource hubRead practical guidance for authorized partners, records, and traceability.Transaction information and statementsLearn about the records that accompany pharmaceutical transfers.ScriptTrack medication workflow softwareExplore the included starter workflow for verified businesses.
Order NDC 42385-0915-30 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).